N/A
N=102
With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care
Palliative Care
Bottom Line
View on ClinicalTrials.gov: NCT03736031 ↗Enrolled (actual)
102
Serious AEs
2.9%
Results posted
Oct 2020
Primary outcome: Primary: Patient Health Questionnaire - 9 (PHQ-9) — 5.23; 8.83; 6.77; 7 score on a scale — p=0.09
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intervention (Promotora) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Texas Tech University Health Sciences Center, El Paso
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Health Questionnaire - 9 (PHQ-9) |
5.23; 8.83; 6.77; 7 | 0.09 |
| PRIMARY Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal) |
138.93; 126.43; 134.04; 119.17 | 0.81 |
| SECONDARY Emergency Department Visits |
1.05; 1.39 | 0.33 |
| SECONDARY Intensive Care Unit Admissions |
2; 1 | 1.0 |
Summary
Despite being strongly recommended, the integration of palliative care in oncology has not been widely adopted. Very few people have access to comprehensive palliative care. Access is even lower in rural and Hispanic communities. Even in communities with access, uptake is often low due to a lack of education on the part of both patients and providers regarding palliative care. This study aims to use an innovative approach to provide quality palliative care to oncology Hispanic patients by using community health workers also known as promotoras.
Eligibility Criteria
Inclusion Criteria
- Must be 18 years or older
- Must be a Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) or University Medical Center (UMC) El Paso patient
- Must be Hispanic
- Must have a cancer diagnosis
Exclusion Criteria
- Under 17 years of age
- Not Hispanic
- Is not a patient of UMC or TTUHSC El Paso
Data sourced from ClinicalTrials.gov (NCT03736031). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.